Insider Trading activities of Dova Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dova Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dova Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Dova Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is DOVA. The reporting company's CIK number is 1685071.
The total value of stock buying since 2005 is $18,692,755.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $180,517.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dova Pharmaceuticals, Inc. (DOVA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-06 466,700 $12,766,325 0 $0 11,000 $80,520
2017-12 0 $0 0 $0 26,809 $99,997
2017-08 46,039 $1,031,030 0 $0 0 $0
2017-07 283,200 $4,895,400 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Dova Pharmaceuticals, Inc. insiders (DOVA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-06-11 Edelman Joseph (10% Owner) Buy 19,700 29.50 581,150
2018-06-08 Edelman Joseph (10% Owner) Buy 25,000 28.80 719,875
2018-06-07 Manning Paul B (Director) Buy 10,000 27.77 277,750
2018-06-07 Edelman Joseph (10% Owner) Buy 50,000 28.40 1,419,850
2018-06-06 Goldman Steven M. (Director) Option Ex 11,000 7.32 80,520
2018-06-06 Manning Paul B (Director) Buy 17,000 28.85 490,450
2018-06-06 Edelman Joseph (10% Owner) Buy 100,000 28.64 2,864,500
2018-06-05 Goldman Steven M. (Director) Buy 15,000 26.41 396,150
2018-06-05 Manning Paul B (Director) Buy 100,000 26.48 2,648,500
2018-06-05 Edelman Joseph (10% Owner) Buy 100,000 26.30 2,629,700
2018-06-04 Manning Paul B (Director) Buy 20,000 24.39 487,700
2018-06-04 Edelman Joseph (10% Owner) Buy 10,000 25.07 250,700
2017-12-22 Sapir Alex (President & CEO) Option Ex 26,809 3.73 99,997
2017-08-16 Pbm Capital Investments, Llc (10% Owner) Buy 5,000 25.77 128,835
2017-08-15 Pbm Capital Investments, Llc (10% Owner) Buy 20,870 21.77 454,444
2017-08-15 Goldman Steven M. (Director) Buy 20,169 22.20 447,751
2017-07-05 Laliberte Kevin (Sr. VP, Product Development) Buy 6,200 17.00 105,400
2017-07-05 Sapir Alex (President & CEO) Buy 20,100 17.00 341,700
2017-07-05 Pbm Capital Investments, Llc (10% Owner) Buy 150,000 17.00 2,550,000
2017-07-05 Goldman Steven M. (Director) Buy 72,000 18.12 1,305,000
2017-07-05 Allen Lee F Md Phd (Chief Medical Officer) Buy 3,500 17.00 59,500
2017-07-05 Jeffs Roger (Director) Buy 31,400 17.00 533,800

Insider trading activities including stock purchases, stock sales, and option exercises of DOVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dova Pharmaceuticals, Inc. (symbol DOVA, CIK number 1685071) see the Securities and Exchange Commission (SEC) website.